Scientists Develop a Synthetic Solution to Combat Dwindling Supply of Cancer and HIV Drug

News   Oct 19, 2017 | Original story written by Nathan Collins for Stanford University

 
Scientists Develop a Synthetic Solution to Combat Dwindling Supply of Cancer and HIV Drug

Stanford scientists have developed a synthetic substitute for a drug derived from Bugula neritina, or spiral-tufted bryozoan. (Image credit: Fitzgerald Marine Reserve Docent/Creative Commons)

 
 
 

RELATED ARTICLES

Existing 20-year-old Multiple Sclerosis Drug Effective Against Multi-resistant Bacteria

News

A widely-used and twenty-year-old medicine used to treat multiple sclerosis can also beat a type of multi-resistant bacteria for which there are currently only a few effective drugs.

READ MORE

A Structural Clue to Attacking Malaria’s ‘Achilles Heel’

News

Researchers have shed light on how the human immune system recognizes the malaria parasite though investigation of antibodies generated from the RTS,S malaria vaccine utilising X-ray crystallography and other sophisticated imaging technologies. This work could boost the development of a more potent vaccine against the global killer.

READ MORE

Antibiotic Resistance: Researchers Succeed in Blocking Genes of Resistance

News

Scientists have come up with a novel approach to block the transfer of resistance genes between bacteria via plasmids. Libraries of small chemical molecules were screened for those that bound an essential component of the plasmid transfer machinery. Analysis by X-ray crystallography revealed the exact binding site of these molecules.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE